Previous 1 2 3 4 5 Next
Profits elusive, but biotech still lures investors
The biotechnology industry has yet to turn a profit but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product lines. Biotech companies worldwide raised nearly... (Tue, 20 May 2008 04:42:00 GMT)
Superefficient Frankencrops Could Put a Real Dent in Greenhouse Gas Emissions
Keeping 6 billion people fed boosts global warming more than all the world's cars, trucks, trains, ships, and planes put together. Agriculture accounts for almost 14 percent of greenhouse gas emissions worldwide, according to the latest report from the Intergovernmental Panel on Climate Change. One response is to eat fewer of the two- and four-legged greenhouse gas factories known as ... (Tue, 20 May 2008 04:58:40 GMT)
NIH Signs a Multi-Year Deal With Active Motif for AKS2 Software
Active Motif and Bioalma announced today that the Center for Information Technology at the National Institutes of Health has signed a multi-year deal to license AlmaKnowledgeServer 2 software, a knowledge discovery system based on unique text mining methodologies developed by Bioalma. CIT will use AKS2 to support an annotation platform for the human salivary proteome project. (Tue, 20 May 2008 05:00:00 GMT)
AstraZeneca, Bristol Help Push Biotechnology Deals to Record
May 20 (Bloomberg) -- Biotechnology acquisitions and licensing deals reached a record $27 billion worldwide last year as drugmakers including AstraZeneca Plc and Bristol-Myers Squibb Co., made purchases to bolster their product offerings. (Tue, 20 May 2008 05:30:47 GMT)
AstraZeneca, Bristol Help Drug Purchases Reach Record (Update1)
May 20 (Bloomberg) -- Biotechnology acquisitions and licensing deals reached a record $27 billion worldwide last year as drugmakers including AstraZeneca Plc and Bristol-Myers Squibb Co., made purchases to bolster their product offerings. (Tue, 20 May 2008 08:28:42 GMT)
Prostate cancer genes mapping paves the way for future treatments
Washington, May 20 : Scientists from the YCR Cancer Research Unit at the University of York and Pro-cure Therapeutics Ltd have reported a novel discovery of a specific gene expression profile of prostate cancer stem cells, which may have important implications for future treatments. (Tue, 20 May 2008 11:00:53 GMT)
Genome-Wide Study Rapidly Scans DNA For Clues, Narrows Search For New Melanoma Gene
It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Despite years of research and clinical development, melanoma incidences continue to rise around the world. (Tue, 20 May 2008 11:13:08 GMT)
Mapping of prostate cancer genes opens the door to new treatments
Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments. (Tue, 20 May 2008 11:35:17 GMT)
Xceed Molecular Features Ziplex Automated Gene-Expression System At The Biomarker World Congress
Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that the company will feature its Ziplex Automated Gene-Expression System at Biomarker World Congress (Tue, 20 May 2008 11:48:28 GMT)
QuantRx Announces Multi Year Agreement with CytoCore for Exclusive Distribution of QuantRx's PADKit(R) for Cytology ...
DOYLESTOWN, Pa.----QuantRx Biomedical Corporation, , a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has entered into an agreement with CytoCore Inc. to supply its PADKit® Collection Kit to provide samples for Cytology and ... (Tue, 20 May 2008 12:26:00 GMT)
QuantRx Announces Multi Year Agreement with CytoCore for Exclusive Distribution of QuantRx's PADKit(R) for Cytology ...
QuantRx Biomedical Corporation, (OTCBB:QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has entered into an agreement with CytoCore Inc. to supply its PADKit(R) Collection Kit to provide samples for Cytology and Human ... (Tue, 20 May 2008 13:03:06 GMT)
Mapping Of Prostate Cancer Genes Opens The Door To New Treatments
Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments. (Tue, 20 May 2008 13:11:38 GMT)
Investors' hopes, not profits, keep biotech thriving
San Francisco- The biotechnology industry has yet to turn a profit, but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product lines. (Tue, 20 May 2008 13:16:02 GMT)
XDx Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
BRISBANE, Calif.----XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced today that it has appointed Jay M. (Tue, 20 May 2008 14:00:00 GMT)
Determining genetic signature of lung tumors can help guide treatment
The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line treatment rather than after standard chemotherapy has failed. (Tue, 20 May 2008 14:20:35 GMT)
XDx Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced today that it has appointed Jay M. Moyes, a 30-year veteran of the finance and biotechnology industries, as its chief financial officer. (Tue, 20 May 2008 14:50:44 GMT)
Mapping Of Prostate Cancer Genes Opens The Door To New Treatments
Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments. The findings revealed 581 genes that are differentially expressed in certain prostate cancer cells, highlighting several ... (Tue, 20 May 2008 15:26:17 GMT)
Profits elusive, but biotech still lures investors
The biotechnology industry has yet to turn a profit but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product lines. (Tue, 20 May 2008 16:02:05 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Tue, 20 May 2008 18:05:15 GMT)
Quick Screening Tool Makes Fast Work of Sorting Crime Samples Promega Launches PowerPlex(R) S5 System
MADISON, Wis.----Promega Corporation announces a new five loci STR system that simplifies and accelerates sorting through samples collected at a crime scene. The new PowerPlex® S5 is designed to help DNA labs efficiently and effectively process the growing number of DNA samples that can come from a single crime scene. (Tue, 20 May 2008 19:00:00 GMT)
Quick Screening Tool Makes Fast Work of Sorting Crime Samples Promega Launches PowerPlex(R) S5 System
Promega Corporation announces a new five loci STR system that simplifies and accelerates sorting through samples collected at a crime scene. The new PowerPlex(R) S5 is designed to help DNA labs efficiently and effectively process the growing number of DNA samples that can come from a single crime scene. In these cases, a quick screening of the samples can be done to identify contributors and ... (Tue, 20 May 2008 19:17:47 GMT)
Brain Cancer Science and Treatment Information
Resources For Reporters (Tue, 20 May 2008 23:27:00 GMT)
BioWorld International Correspondent
Genetic Chemistry, of Palo Alto, Calif., will deploy Evolva's metabolic engineering platform in the program. That involves the creation of artificial yeast chromosomes containing genes isolated from multiple natural sources, which can form new biosynthetic pathways that give rise to novel compounds. (Tue, 20 May 2008 23:29:25 GMT)
Unique adaptive evolution in snake proteins -- insight into vertebrate physiology
Prior to the advent of large sequence datasets, it was assumed that innovation and divergence at the morphological and physiological level would be easily explained at the molecular level. Molecular explanations for physiological adaptations have, however, been rare. (Wed, 21 May 2008 00:05:40 GMT)
First Draft of Oil Palm Genome Completed by Synthetic Genomics Inc and Asiatic Centre for Genome Technology
Asiatic Centre for Genome Technology Sdn Bhd , which is focused on the commercial application of genome technology to improve oil palm and other crops and Synthetic Genomics Inc. , a privately held company dedicated to commercializing genomic-driven solutions to address global energy and environmental challenges, today announced the completion of a first draft assembly and annotation of the oil ... (Wed, 21 May 2008 04:00:00 GMT)
Newborn Blood-Storage Law Stirs Fears of DNA Warehouse
An obscure bill that sailed through Congress and was signed into law last month is stoking fears of a nationwide DNA warehouse potentially open to abuse by law enforcement agencies or health insurance companies. But proponents say the law is a much-needed rationalization of the way the government stores and tests blood from newborns. The Newborn Screening Saves Lives Act of 2007 ( ... (Wed, 21 May 2008 04:11:48 GMT)
CSIRO to close Rockhampton livestock labs
In consolidating its agricultural research resources for northern Australia, CSIRO has announced it will be closing its JM Rendel Laboratory in Rockhampton. (Wed, 21 May 2008 04:31:46 GMT)
Big Pharma biotech deals worth $27B in'07
Biotechnology acquisitions and licensing deals reached a record $27 billion worldwide last year as drugmakers, including AstraZeneca and Bristol-Myers Squibb, made purchases to bolster their product offerings. (Wed, 21 May 2008 04:51:49 GMT)
Hurdling a cultural divide - roanoke.com
For academics, making the transition from the lab to the business world can be a challenge. BLACKSBURG -- When it comes to navigating the business world, entrepreneurially minded professors often find themselves at a bit of a disadvantage. Accustomed to publication-based promotion and niche-specific jargon, the adjustment to bottom-line-oriented, give-it-to-me-straight boardrooms can take ... (Wed, 21 May 2008 05:41:38 GMT)
21-05-2008: Biotech industry needs up to RM100m for commercialisation
KUALA LUMPUR: Some RM80 million to RM100 million in public-sector investment is needed within the next two to three years to gear up the biotech industry for commercialisation, Malaysian Biotech Corp chief executive Datuk Iskandar Mizal Mahmood said yesterday. (Wed, 21 May 2008 07:06:40 GMT)
The world's strongest man
Augie Nieto is losing muscle to Lou Gehrig's disease. Now, he's tougher than ever. (Wed, 21 May 2008 07:54:07 GMT)
DNAPrint shifts its shares
DNAPrint Genomics, the genetics testing company, has moved from an over the counter listing to the pink sheets something it is telling investors it is doing to save money. (Wed, 21 May 2008 08:44:47 GMT)
Boost for cancer research in Leicestershire
A new approach to pain relief, investigation of a gene that triggers colorectal cancer and the prevention, early diagnosis and treatment of ovarian cancer are three research projects at the University of Leicester, which are to benefit from funding from the Leicestershire and Rutland charity Hope Against Cancer. (Wed, 21 May 2008 09:33:15 GMT)
European Network Of Biological Samples Key To Develop New Cures For Complex Diseases
A seminar to explore the challenges and requirements to create a European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) will take place at the EU Parliament on 28 May 2008. Medical and health research have evolved very quickly in the last decades based on path-breaking advances and discoveries in genomics and molecular biology. (Wed, 21 May 2008 10:12:18 GMT)
Malaysia's Asiatic unveils oil palm genome draft
KUALA LUMPUR, May 21 - Malaysia's Asiatic Development Bhd and a U.S. research firm said on Wednesday they made the first draft sequence of the oil palm genome, which when complete could raise crop yields by 30 percent. (Wed, 21 May 2008 11:10:14 GMT)
454 Sequencing Used at Institute of Genomics & Integrative Biology (IGIB) in India
Branford, Conn.----Roche has successfully installed the first Genome Sequencer FLX System at the prestigious IGIB, in Delhi, India. IGIB plans to use the system for all applications possible within this revolutionary technology, with a special focus on metagenomics and de novo genome sequencing. (Wed, 21 May 2008 12:00:00 GMT)
American Company to Offer Dog Cloning Service at International Public Auction
BioArts International (BioArts), today announced that it will sell five dog cloning service slots to the general public via a worldwide, online auction to be held June 18th. (Wed, 21 May 2008 12:00:00 GMT)
Rosetta Genomics Reports First Quarter 2008 Financial Results
- (Wed, 21 May 2008 12:30:00 GMT)
Rosetta Genomics Reports First Quarter 2008 Financial Results
Rosetta Genomics, Ltd. , a leading molecular diagnostics company, reported today its consolidated financial results for the quarter ended March 31, 2008 and business highlights. (Wed, 21 May 2008 12:30:00 GMT)
454 Sequencing Used at Institute of Genomics & Integrative Biology (IGIB) in India
Roche has successfully installed the first Genome Sequencer FLX System at the prestigious IGIB, in Delhi, India. IGIB plans to use the system for all applications possible within this revolutionary technology, with a special focus on metagenomics and de novo genome sequencing. The Centre for Genomic Application (TCGA) will provide the sequencing services to the customers. (Wed, 21 May 2008 12:32:19 GMT)
DNAPrint shifts its shares
DNAPrint Genomics, the genetics testing company, has moved from an over-the-counter listing to the pink sheets -- something it is telling investors it is doing to save money. (Wed, 21 May 2008 13:44:33 GMT)
Rosetta Genomics' Q1 Loss Nearly Doubles
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 21 May 2008 14:44:49 GMT)
Oil palm genome sequencing may aid sustainability
California-based Synthetic Genomics (SGI) and the Asiatic Centre for Genome Technology Sdn Bhd ( ACGT ) announced the joint venture last year, with the aim of developing more high-yielding and disease-resistant crops. (Wed, 21 May 2008 17:29:55 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Wed, 21 May 2008 17:49:32 GMT)
Synthetic Genomics, Malaysian Company Sequence Draft of Oil Palm Genome
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 21 May 2008 20:14:59 GMT)
Affymetrix Applauds Congress and President for Enacting the Genetic Information Nondiscrimination Act
SANTA CLARA, Calif.----Affymetrix Inc. applauds the U.S. Congress and President George W. Bush for enacting the Genetic Information Nondiscrimination Act . GINA establishes a much-needed federal prohibition in the United States against genetic discrimination and enacts a national standard for ensuring the privacy of personal genetic information. (Wed, 21 May 2008 21:00:00 GMT)
Affymetrix Applauds Congress and President for Enacting the Genetic Information Nondiscrimination Act
Affymetrix Inc. (367;Nasdaq:AFFX) applauds the U.S. Congress and President George W. Bush for enacting (Wed, 21 May 2008 21:19:20 GMT)
Asiatic, US partner make progress in R&D on oil palm genome
KUALA LUMPUR: Asiatic Development Bhd’s wholly-owned subsidiary Asiatic Centre for Genome Technology Sdn Bhd (ACGT) and US-based Synthetic Genomics Inc (SGI) have completed the first draft assembly and annotation of the oil palm genome. (Wed, 21 May 2008 23:22:20 GMT)
PEOPLE IN THE NEWS, MAY 22, 2008
Kansas State University students Aubrey Bamford of Andover, Nathan Harms , Zach Marteney and Austin Rogers, all of Derby, and Krista McKay of Halstead participated in the university's ninth annual Undergraduate Research Forum. Students are listed with their choice of research: Bamford, a junior in biology, "Comparison of Thoracic Radiography and Computed Tomography for Detection of ... (Thu, 22 May 2008 06:06:50 GMT)
Promethease Wins 23andMe "Crystal Ball" Personal Genomics Contest
Describe a real woman's looks, likes and health issues based only on her DNA. Mike Cariaso used Promethease software plus information from SNPedia about DNA variations known as SNPs (both freely available to individuals) to do just that and won a contest held by the personal genomics company 23andMe. (Thu, 22 May 2008 07:01:00 GMT)
By GIB SNYDER
It will be an economic development project. That was the thrust of a presentation about the SUNY Fredonia Technology Incubator project given Wednesday at the Northern Chautauqua Community Foundation. (Thu, 22 May 2008 07:17:30 GMT)
Promethease Wins 23andMe "Crystal Ball" Personal Genomics Contest
Describe a real woman's looks, likes and health issues based only on her DNA. Mike Cariaso used Promethease software plus information from SNPedia about DNA variations known as SNPs (both freely available to individuals) to do just that and won a contest held by the personal genomics company 23andMe. (PRWeb May 22, 2008) Read the full story at ... (Thu, 22 May 2008 07:44:41 GMT)
Genomics Is Transforming The Pharmaceutical Industry
Research and Markets (http://www.researchandmarkets has announced the addition of "Genomics World Markets 2008" to their offering. (Thu, 22 May 2008 11:20:00 GMT)
Genomics Is Transforming The Pharmaceutical Industry
DUBLIN, Ireland----Research and Markets has announced the addition of "Genomics World Markets 2008" to their offering. (Thu, 22 May 2008 11:20:00 GMT)
Company Adds New Kits to Differentiate Mesenchymal Stem Cells
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. (Thu, 22 May 2008 12:16:57 GMT)
Invitrogen Launches First Ever Serum Free Media for Mes.
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. (Thu, 22 May 2008 12:17:11 GMT)
Invitrogen Launches First Ever Serum Free Media for Mes.
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. (Thu, 22 May 2008 12:17:18 GMT)
Invitrogen Launches First Ever Serum Free Media for Mesenchymal Stem Cells
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. STEMPRO(R) MSC SFM is a first of its kind product that overcomes many challenges in MSC culture. In concert, ... (Thu, 22 May 2008 13:18:48 GMT)
Text size
A new powerhouse of scientific research is set to emerge from Cambridge following the decision to merge the University's Institute of Biotechnology and Department of Chemical Engineering. (Thu, 22 May 2008 15:03:19 GMT)
U-M Diabetes Center Receives $8.9M Grant
Diabetes researchers at the U-M Health System have won a five-year, $8.9 million federal grant that will accelerate a broad range of studies aimed at understanding diabetes and its complications, and addressing the epidemic of type 2 diabetes that threatens to wreak havoc on the American public's health for decades to come. (Thu, 22 May 2008 15:28:36 GMT)
VistaGen Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa, a Japanese Pharmaceutical Company
SOUTH SAN FRANCISCO, Calif.----VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell technologies for predictive toxicology and drug discovery, today announced that Sanwa Kagaku Kenkyusho Co. (Thu, 22 May 2008 16:00:00 GMT)
VistaGen Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa, a Japanese Pharmaceutical Company
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, today announced that Sanwa Kagaku Kenkyusho Co. Ltd. (Sanwa), an international pharmaceutical company headquartered in Nagoya, Japan, has, pursuant to the terms of the parties' joint research and development agreement, selected to ... (Thu, 22 May 2008 16:17:56 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Thu, 22 May 2008 17:49:49 GMT)
Italy's Contributions to Biotechnology Innovation to Be Featured at 2008 BIO International Convention
WASHINGTON----The 2008 BIO International Convention will highlight the growth of Italy's biotechnology industry with more than 50 biotechnology-based organizations from Italy anticipated to participate. (Thu, 22 May 2008 18:56:00 GMT)
Tips from the Journals of the American Society for Microbiology
For the first time researchers from Australia and The Netherlands examine the inflammatory response induced by macrophages that may contribute to the development of gastritis during Helicobacter pylori infection in mice. (Thu, 22 May 2008 19:50:35 GMT)
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits AnaSpec Inc. Posted on: 23 May 08
This week AnaSpec, a world leader in integrated proteomics solutions, introduced sixty (60) new catalog peptides and three (3) new assay kits. Hylambatin belongs to the tachykinins. (Fri, 23 May 2008 16:41:47 GMT)
Important Plant Enzymes Identified
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified enzymes important in the modification of isoflavonoids, natural plant products that help plants resist fungal infections, and may have beneficial health effects for humans as well. The research, which will be published online May 22, 2008, in The Plant Journal, may pave the way for implanting the ... (Fri, 23 May 2008 17:35:16 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Fri, 23 May 2008 17:49:42 GMT)
Virginia Tech’s Green500 List submission deadline: June 13, 2008
Virginia Tech’s Green500 List originally debuted in November 2007 at the Supercomputing 2007 (SC07) conference. Its purpose was to provide a foundation for tracking trends in green supercomputing. (Fri, 23 May 2008 17:55:18 GMT)
Genetic Variation May Explain Preferences for Sugar
FRIDAY, May 23 (HealthDay News) -- A new study says you might be able to blame your sweet tooth on your genes. (Fri, 23 May 2008 18:02:14 GMT)
Final Judgment of $35.7 Million Entered by Federal Court: CombiMatrix Will Seek to Collect
MUKILTEO, Wash., May 23, 2008 -- The United States District Court for the Central District of California has entered a Final Judgment in favor of CombiMatrix Corporation in the amount of $35.7 million, to be paid by National Union Fire Ins. (Fri, 23 May 2008 19:20:47 GMT)
Genetic Variation May Explain Preferences for Sugar
Copyright © 2008 ScoutNews LLC. All rights reserved. FRIDAY, May 23 (HealthDay News) -- A new study says you might be able to blame your sweet tooth on your genes. (Fri, 23 May 2008 19:29:22 GMT)
Genetic Variation May Explain Preferences for Sugar
Finding could help research into soaring obesity, diabetes rates, study says. (Fri, 23 May 2008 20:06:44 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Sat, 24 May 2008 17:49:41 GMT)
Medical College aims higher
The Medical College of Wisconsin has been one of the fastest-growing medical schools in the country during the last 10 years. (Sun, 25 May 2008 00:04:40 GMT)
Memoir at 27 a winner for author with NZ connections
Robyn Scott says "bloody-mindedness" led to her writing her just-released first book, Twenty Chickens for a Saddle. (Sun, 25 May 2008 00:37:01 GMT)
Enterprise Center names winner of business plan competition
“Imagine a generation from now you go to the doctor’s and they can log on to all the different disease states possible and tell whether you’ll have that disease,” said Phil Holberton, co-owner of Differential Proteomics (DP), a small Beverly biotech company that uses patented technology to target disease indicative proteins found in the blood. (Sun, 25 May 2008 04:29:54 GMT)
Cyber still uncharted business realm
It doesn't make products like widgets or hamburgers, but boosters hope cyber will soon become a landmark on the area business horizon, buttressing more tradition sources of area employment and revenue. (Sun, 25 May 2008 07:08:04 GMT)
Clinical And Translational Applications Of Small, Non-Coding RNAs In The Initiation And Progression Of Urological ...
UroToday.com - Dr. deVere White stated that miRNA are involved in gene amplification and alteration. They are tissue, cancer and cell cycle specific. This adds complexity to the their understanding. miRNA-155 B in lymphoma is an example of overexpression in a tumor. Global miRNA profiling requires validation with Northern blotting, real time PCR for example otherwise there will be false targets. (Sun, 25 May 2008 08:13:08 GMT)
Science & Technology Top Story
Science is ringing in a new era in the world of the hearing-impaired, and the technologies to accommodate, treat and prevent hearing loss -- and even cure it -- are advancing at almost sonic speed. (Sun, 25 May 2008 08:37:11 GMT)
News From The Journals Of The American Society For Microbiology
Immune Cells May Induce Gastritis During H. pylori InfectionFor the first time researchers from Australia and The Netherlands examine the inflammatory response induced by macrophages that may contribute to the development of gastritis during Helicobacter pylori infection in mice. They report their findings in the May 2008 issue of the journal Infection and Immunity.H. (Sun, 25 May 2008 12:10:38 GMT)
Clinical And Translational Science: Diseases Targeted At Molecular Level Before Patient Feels Sick
If you were sick, wouldn't you prefer a customized medical treatment that works specifically for you? Or a treatment that prevents you from ever getting sick in the first place? The emerging field of clinical and translational science provides the bridging force that transforms lab discoveries into customized, patient-specific therapy. Deputy Editor, Scott A. (Sun, 25 May 2008 14:10:38 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Sun, 25 May 2008 17:49:42 GMT)
Session preps innovators for investors
Matthew Disney recognizes the fundamental difficulty of being a scientist with an idea to sell. (Mon, 26 May 2008 04:48:26 GMT)
2008 BIO International Convention's Innovation Corridor To Highlight The Future Of Biotechnology
Academics and industry leaders will showcase their innovative ideas on the next groundbreaking technologies in the life sciences at the 2008 BIO International Convention's Innovation Corridor poster sessions. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take place June 17-20 at the San Diego Convention Center in San Diego, Calif. (Mon, 26 May 2008 08:11:58 GMT)
Unlocking The Promise Of Clinical And Translational Science
If you were sick, wouldn't you prefer a customized medical treatment that works specifically for you? Or a treatment that prevents you from ever getting sick in the first place? The emerging field of clinical and translational science provides the bridging force that transforms lab discoveries into customized, patient-specific therapy. Deputy Editor, Scott A. (Mon, 26 May 2008 09:10:38 GMT)
Dutch scientists first to sequence female DNA
Geneticists of Leiden University Medical Centre (LUMC) are the first to determine the DNA sequence of a woman. She is also the first European whose DNA sequence has been determined. This has been announced by the researchers this morning, during a special press conference at ‘Bessensap`, a yearly meeting of scientists and the press in the Netherlands. (Mon, 26 May 2008 15:05:16 GMT)
RNAi co Alnylam COO looks to Israel visit
Barry Greene: I want to visit Israel and to seek deals. (Mon, 26 May 2008 16:27:32 GMT)
Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Mon, 26 May 2008 18:04:44 GMT)
First Female DNA Sequenced
Geneticists have, for the first time, determined the DNA sequence of a woman. She is also the first European whose DNA sequence has been determined. Following in-depth analysis, the sequence will be made public, except incidental privacy-sensitive findings. The results will contribute to insights into human genetic diversity. (Mon, 26 May 2008 20:11:58 GMT)
Billions invested into genetic drugs
BIOTECHNOLOGY: The industry hasn't turned a profit, but worldwide financing is up almost $2 billion from 2006. (Mon, 26 May 2008 21:52:09 GMT)
LSUS to be leader in bioinformatics
The university's new push comes after last month's approval by the Louisiana State Board of Supervisors to change its role, scope and mission statement. The program still needs approval by the state's Board of Regents. (Tue, 27 May 2008 07:05:32 GMT)
Immune cells caught attacking pancreas
It's long been thought that type 1 diabetes is caused when the body's own immune cells begin attacking the pancreas. (Tue, 27 May 2008 08:09:37 GMT)
Clinical Information Systems in Oncology Show Significant Cost Benefits
LONDON----The positive attitude of healthcare providers towards oncology information systems is growing as the European healthcare industry is looking for a broad mix of services and solutions. (Tue, 27 May 2008 08:45:00 GMT)
Munich, Germany May 27, 2008 A consortium funded in frame of the German Plant Genome Program "GABI" has selected ...
as partner for sequencing and assembling of gene-rich parts of the barley genome. The project is carried out by multiplex sequencing of pools of BAC clones with Roche GS FLX / 454 technology and customised software solutions. (Tue, 27 May 2008 11:15:23 GMT)
Applied Biosystems/MDS Analytical Technologies to Demonstrate Productivity Solutions at International Mass ...
DENVER----Mass spectrometry, which was until recently a complicated technology available exclusively to highly trained experts, is today a workhorse analytical technique for a wide variety of scientific applications including basic research, drug discovery and development, food and environmental contamination testing and forensic analysis. (Tue, 27 May 2008 11:30:00 GMT)
Get a Deep Insight into the Genomics World Markets
Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. (Tue, 27 May 2008 11:53:00 GMT)
JMP(R) Genomics 3.2 Enhances Data Discoveries
CARY, N.C.----JMP Genomics 3.2, now available from SAS, streamlines analysis workflows for expression, exon, copy number and genotype data. Building on the powerful analytic and visualization capabilities of the SAS®9 and JMP 7 platforms, the latest release of this comprehensive desktop genomics package also simplifies integration with partner technologies. (Tue, 27 May 2008 12:00:00 GMT)
Biotique Systems Launches Innovative Data Management Solution for Next-Generation Sequencing Platforms
RENO, Nev.----Biotique Systems, Inc. today announced the availability of a new research and development productivity solution that provides an enterprise-scale informatics environment for integrating, analyzing and sharing data generated by next-generation sequencing platforms. (Tue, 27 May 2008 12:01:00 GMT)
febit Receives U.S. Patent for Microfluidic Extraction Method
febit today announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA. (Tue, 27 May 2008 12:30:00 GMT)
Thermo Fisher Scientific and George Mason University Partner in Groundbreaking Protein Biomarker Research Project
WALTHAM, Mass.----Thermo Fisher Scientific Inc. , the world leader in serving science, today announced an alliance between its Biomarker Research Initiatives in Mass Spectrometry Center and George Mason University's Center for Applied Proteomics and Molecular Medicine to accelerate biomarker validation and forge new breakthroughs in early disease diagnosis. (Tue, 27 May 2008 12:45:00 GMT)
RFID Tag Performs Reliably, Efficiently In Any Environment
The Information and Telecommunication Technology Center (ITTC) at the University of Kansas is seeking licensees for its Agility Tag, a new radio frequency identification (RFID) technology that enables one tag to work in contrary environments. (Tue, 27 May 2008 13:07:33 GMT)
DNA Clues To Reproductive Behavior
A species of wild yeast goes through a cycle of sexual reproduction once in every 1,000 asexual generations, according to new research. The study focused on the wild yeast Saccharomyces paradoxus, which is able to reproduce both sexually and asexually. The scientific team used this yeast to examine how sexual and asexual reproduction cause different types of variations in an organism's DNA ... (Tue, 27 May 2008 14:29:59 GMT)
Thermo Fisher teams with George Mason University on biomarker project
Thermo Fisher Scientific Inc. has formed an alliance with George Mason University to accelerate biomarker validation and forge new breakthroughs in early disease diagnosis, the company said on Tuesday. (TMO) (Tue, 27 May 2008 14:55:20 GMT)
Biotique Systems Launches Innovative Data Management Solution for Next-Generation Sequencing Platforms
Biotique Systems, Inc. today announced the availability of a new research and development productivity solution that provides an enterprise-scale informatics environment for integrating, analyzing and sharing data generated by next-generation sequencing platforms. HT-BLIS (High-Throughput HT-BLIS) allows academic and commercial research organizations to process, in real time, the massive amounts ... (Tue, 27 May 2008 16:36:17 GMT)
Chr Hansen homes in on nutrigenomic probiotics
The Danish probiotics specialist is involved in several genomic research projects that explore the idea of matching nutritional input to genetic make-up to yield the most positive health results. (Tue, 27 May 2008 16:43:40 GMT)
PENN Medicine News: New Links in Tobacco Carcinogen Chemical Pathway
PHILADELPHIA – Two types of cancer-causing agents in cigarettes—a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer. (Tue, 27 May 2008 16:52:47 GMT)
HHMI Funds Genomics, Related Areas with $600M in 2008 Investigator Awards
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 27 May 2008 19:59:59 GMT)
febit receives U.S. patent for microfluidic extraction method
febit today announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA. (Tue, 27 May 2008 20:31:46 GMT)
Scientists sequence first female DNA
Geneticists of Leiden University Medical Centre (LUMC) are the first to determine the DNA sequence of a woman. She is also the first European whose DNA sequence has been determined. This has been announced by the researchers this morning, during a special press conference at 'Bessensap', a yearly meeting of scientists and the press in the Netherlands. (Tue, 27 May 2008 20:32:21 GMT)
GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation
GenoLogics, the leading developer of translational research informatics solutions for life sciences organizations, today announced its partnership with GenVault Corporation for its biospecimen data management system, BioVault. (Tue, 27 May 2008 20:35:00 GMT)
Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers. (Tue, 27 May 2008 21:28:03 GMT)
More News
In four weeks, she’ll know for sure. Tori was one of eight mystery mutts to receive a doggie DNA test Saturday morning at the PETCO on Middlebrook Road in Germantown to determine their breeds. (Tue, 27 May 2008 21:33:09 GMT)
Estrogen helps drive distinct, aggressive form of prostate cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers. (Tue, 27 May 2008 21:50:37 GMT)
Large-scale community protein annotation -- WikiProteins
Today sees the launch of a new collaborative website initially focusing on proteins and their role in biology and medicine. The WikiProfessional technology underlying the site has been developed based upon the collaborative Wikipedia approach. Described in BioMed Central's open access journal Genome Biology, WikiProteins provides a method for community annotation on a huge scale. (Tue, 27 May 2008 23:06:15 GMT)
High throughput microscopy quantifies regulation of estrogen receptor
High throughput microscopy that uses robots and special microscopes and techniques to generate thousands of images of a cell in a short time enabled researchers at Baylor College of Medicine in Houston to describe how the genetic message of estrogen receptor-alpha is regulated, a finding that could have implications for breast cancer. (Wed, 28 May 2008 00:06:45 GMT)
BIOTECH: Convention emphasizes environment, county's biotech strengths
San Diego County's large biotechnology community opens its doors to the world next month, when the biggest biotech conference comes to town. (Wed, 28 May 2008 02:48:10 GMT)
Profits are elusive, but biotech still attracts investors
SAN FRANCISCO — The biotechnology industry has yet to turn a profit, but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product lines. (Wed, 28 May 2008 07:22:34 GMT)
Estrogen Helps Drive Distinct, Aggressive Form Of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.Estrogen-linked signaling helps drive a discrete and aggressive form of the disease caused by a chromosomal translocation, which in turn results in the fusion of two genes. (Wed, 28 May 2008 08:12:48 GMT)
Johns Hopkins University Purchases Sequenom MassARRAY Platform
Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced the purchase of Sequenom's MassARRAY(R) system by the DNA Diagnostic Lab of the McKusick-Nathans Institute of Genetic Medicine and the Translational Technology Core of the Institute for Translational Clinical Research at Johns Hopkins University School of Medicine. Scientists plan to use the system as ... (Wed, 28 May 2008 08:17:39 GMT)
'Dramatic results' for experimental cancer drug
Tumors are shrinking, Valley researchers report. (Wed, 28 May 2008 08:55:23 GMT)
New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec AnaSpec Inc. Posted on: 27 May 08
Adding to a broad collection of long wavelength FRET protease assay kits, AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit. (Wed, 28 May 2008 09:11:36 GMT)
Clinical Information Systems In Oncology Show Significant Cost Benefits
The positive attitude of healthcare providers towards oncology information systems is growing as the European healthcare industry is looking for a broad mix of services and solutions. This situation is creating the potential for a multi-million dollar industry. New analysis from Frost & Sullivan , Clinical Information Systems in Europe - Oncology, finds that the market was worth $13. (Wed, 28 May 2008 09:13:09 GMT)
Scientists pinpoint estrogen as key player in half of all prostate cancers
Washington, May 28 : Estrogen, known as a 'female hormone', plays a crucial role in the development of almost half of all prostate cancers, a new study has revealed. (Wed, 28 May 2008 09:21:39 GMT)
Gregory C. Pappas, Noted Publisher, to Join X PRIZE Foundation Advisory Council
The X PRIZE Foundation, an educational nonprofit prize institute created to foster radical breakthroughs for the benefit of humanity, announced today that Gregory Pappas, publisher of Greek America Magazine, has been invited to join the Foundation's Advisory Council. As an advisor, Pappas will consult with X PRIZE Foundation Chairman and CEO Dr. (Wed, 28 May 2008 11:00:00 GMT)
High Throughput Microscopy Quantifies Regulation Of Estrogen Receptor
High throughput microscopy that uses robots and special microscopes and techniques to generate thousands of images of a cell in a short time enabled researchers at Baylor College of Medicine in Houston to describe how the genetic message of estrogen receptor-alpha is regulated, a finding that could have implications for breast cancer. (Wed, 28 May 2008 11:12:52 GMT)
Agilent Technologies to Host Technical Forum on Mass Spectrometry with Dr. Ruedi Aebersold at American Society for ...
SANTA CLARA, Calif.----Agilent Technologies today announced it will host a technical forum on mass spectrometry, kicking off its activities at the 2008 American Society for Mass Spectrometry annual conference. (Wed, 28 May 2008 12:00:00 GMT)
Agilent Technologies to Host Technical Forum on Mass Spectrometry with Dr. Ruedi Aebersold at American Society for ...
Agilent Technologies (NYSE:A) today announced it will host a technical forum on mass spectrometry, kicking off its activities at the 2008 American Society for Mass Spectrometry (ASMS) annual conference. The technology forum will be held Saturday, May 31, 5-9:30 p.m. MT at the Hyatt Regency Denver. (Wed, 28 May 2008 12:47:19 GMT)
Two Leading Biotech-Pharma Patent Lawyers Join King & Spalding
King & Spalding, a leading international law firm, continues to add top talent to its growing intellectual property practice, hiring two new partners in the firm's Silicon Valley office, Peter Dehlinger, Ph.D. and Judy M. (Wed, 28 May 2008 13:00:00 GMT)
Waters and Rosetta Biosoftware Achieve Collaborative Milestone
MILFORD, Mass. & SEATTLE----Waters Corporation and Rosetta Biosoftware today announced that the Rosetta Elucidator® system has been enabled to mine Waters® UltraPerformance LC®/MSE, high-bandwidth, proteomics discovery data and integrate the Waters IDENTITYE® search engine for secure protein identifications. (Wed, 28 May 2008 15:00:00 GMT)
Leiden Scientists Sequence First Female DNA
Geneticists of Leiden University Medical Centre (LUMC) are the first to determine the DNA sequence of a woman. She is also the first European whose DNA sequence has been determined. This has been announced by the researchers this morning, during a special press conference at 'Bessensap', a yearly meeting of scientists and the press in the Netherlands. (Wed, 28 May 2008 15:11:13 GMT)
TechInsights(TM) Launches Three New DesignLine(TM) Resource Sites Targeted to European Designers in Strategic Markets
Today, TechInsights announced the formal launch of three DesignLines to directly support European designers working in the power management, industrial control and automotive application spaces. (Wed, 28 May 2008 15:24:00 GMT)
'Dramatic results' for experimental cancer drug
Jerry Coffman lives from scan to scan. Coffman used to live on his La-Z-Boy, wiped out most the time and anticipating hospice care. (Wed, 28 May 2008 15:25:27 GMT)
Waters and Rosetta Biosoftware Achieve Collaborative Milestone
Waters Corporation (NYSE:WAT) and Rosetta Biosoftware today announced that the Rosetta Elucidator(R) system has been enabled to mine Waters(R) UltraPerformance LC(R)/MS(E), high-bandwidth, proteomics discovery data and integrate the Waters IDENTITY(E)(R) search engine for secure protein identifications. Both companies will showcase their integrated solution at the upcoming American Society for ... (Wed, 28 May 2008 15:34:05 GMT)
A new way to look at lung cancer and tobacco carcinogens
Two types of cancer-causing agents in cigarettes—a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer. Exposure to tobacco smoke - both mainstream and second-hand - is a leading cause of cancer death in the United States. (Wed, 28 May 2008 17:05:26 GMT)
'Barren' seafloor teeming with microbial life
Once considered a barren plain with the odd hydrothermal vent, the seafloor appears to be teeming with microbial life, according to a paper being published May 29 in Nature. (Wed, 28 May 2008 17:06:03 GMT)
New Insights Into Cellular Reprogramming Revealed by Genomic Analysis
Recent research has shown that adult mouse and human cells can be transformed, or "reprogrammed" into a primitive, stem-cell state, but the process is inefficient and poorly understood. Now, thanks to the application of powerful new integrative genomic tools, scientists have uncovered significant new information about the molecular changes that underlie the direct reprogramming process. (Wed, 28 May 2008 17:24:31 GMT)
A New Way to Look at Lung Cancer and Tobacco Carcinogens
Previous studies have shown how polycyclic aromatic hydrocarbons (PAHs) damage DNA, with the emphasis on how PAHs bind directly to DNA itself, leading to the mutations in critical genes that cause disease. Now, researchers have shown that PAHs, via oxidative stress, can also led to mutations in critical genes important in lung cancer. (Wed, 28 May 2008 17:27:57 GMT)
'Barren' seafloor teeming with microbial life
Once considered a barren plain with the odd hydrothermal vent, the seafloor appears to be teeming with microbial life, according to a paper being published May 29 in Nature. “A 60,000 kilometer seam of basalt is exposed along the mid-ocean ridge spreading system, representing potentially the largest surface area for microbes to colonize on Earth,” said USC geomicrobiologist Katrina Edwards, the ... (Wed, 28 May 2008 17:50:47 GMT)
'Dramatic results' for cancer drug
Researchers hopeful about tumor-shrinking drug. (Wed, 28 May 2008 17:54:12 GMT)
Genetic testing for everyone
Private companies are starting to test customers' DNA for gene variants linked to an increased risk of conditions such as obesity or Alzheimer's disease. Helen Pearson looks at whether knowledge really is power when it comes to disease avoidance. (Wed, 28 May 2008 18:11:28 GMT)
Microbiology: The inside story
In the second, Apoorva Mandavilli meets the surgeons who have a rare opportunity to watch an ecosystem being established as they transplant guts from one person to another. (Wed, 28 May 2008 18:26:29 GMT)
TechInsights(TM) Launches Three New DesignLine(TM) Resource Sites Targeted to European Designers in Strategic Markets
BRUSSELS, Belgium , May 28 /PRNewswire/ -- Today, TechInsights announced the formal launch of three DesignLines to directly support European designers working in the power management, industrial control and automotive application spaces. (Wed, 28 May 2008 18:44:21 GMT)
Why study Physics? Because it’s fun
Last year Physics students at Miranda House sported sweatshirts that carried the precocious message, “God on holiday, physicist in charge” and the year before that, “Physics is fun!” (Wed, 28 May 2008 19:25:03 GMT)
Genomics Reveals Molecular Changes Behind Cellular Reprogramming
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 28 May 2008 19:45:29 GMT)
EBI to Lead $7M Project to Create Sustainable European Bioinformatics Infrastructure
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 28 May 2008 19:45:59 GMT)
Estrogen drives distinct, aggressive prostate cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers. (Wed, 28 May 2008 19:46:42 GMT)
Genome institute director Collins to resign
Dr. Francis Collins, who helped lead the sequencing of the human gene map, said on Wednesday he was stepping down as director of the U.S. National Human Genome Research Institute. (Wed, 28 May 2008 19:56:42 GMT)
"Barren" Seafloor Teeming with Microbial Life
Seafloor bacteria are more abundant and diverse than previously thought, appearing to "eat" the planet's oceanic crust, according to a new study in Nature. The findings pose intriguing questions about ocean chemistry and the co-evolution of Earth and life. (Wed, 28 May 2008 20:24:15 GMT)
SeedQuest - Central information website for the global seed industry
The Joint Annual Meeting of the American Society of Plant Biologists (ASPB) and the Sociedad Mexicana De Bioquimica Rama: Bioquimica y Biologia Molecular de Plantas will be held June 22–25, 2008 in the Fiesta Americana Hotel in Merida, Mexico. (Wed, 28 May 2008 21:30:48 GMT)
Previous 1 2 3 4 5 Next